METABOLIC STATE OF BLOOD LYMPHOCYTES IN CHRONIC MYELOID LEUKEMIA AND CHRONIC LYMPHOID LEUKEMIA
https://doi.org/10.15789/1563-0625-2008-1-21-26
Abstract
Abstract. We examined metabolic status of blood lymphocytes in forty-four patients with chronic myeloid leukemia (CML), and in fifty-seven patients with chronic lymphoid leukemia (CLL). The most pronounced changes of enzyme activities are found in blood lymphocytes of CML and CLL patients during terminal stage of the disease. All the patients with chronic leukemia at both stages showed a decreased intensity of metabolic processes in blood lymphocytes. In addition, CML patients at both clinical stages exhibited a decrease in antioxidant cell protection. The more pronounced biochemical disturbances in CML patients at progression stage concerned carbohydrate metabolism, whereas the changes at terminal stage of disease affected both carbohydrate and fat metabolism. The most marked biochemical alterations in CLL at progression stage are registered for carbohydrate and protein metabolism, and carbohydrate, fat and protein metabolism at terminal stage of disease. The revealed changes showed indicate to more severe clinical course in the patients with CML. These changes and differences depict some aspects of immune pathogenesis in development and progression of CML and CLL.
About the Authors
O. V. Smirnova
ГУ НИИ Медицинских проблем Севера СО РАМН, г. Красноярск
Russian Federation
Russian Federation
V. T. Manchuk
ГУ НИИ Медицинских проблем Севера СО РАМН, г. Красноярск
Russian Federation
Russian Federation
A. A. Savchenko
ГУ НИИ Медицинских проблем Севера СО РАМН, г. Красноярск
Russian Federation
Russian Federation
References
1. Березов Т.Т., Коровкин Б.Ф. Биологическая химия. – М.: Медицина, 1998. – 704 с.
2. Волкова М.А. Клиническая онкогематология. – М.: Медицина, 2001. – 576 с.
3. Воробьев А.И. Руководство по гематологии: в 3 т. Т. 1. – М.: Ньюдиамед, 2002. – 280 с.
4. Доронин В.А. Текущие аспекты патогенеза и диагностики хронического лимфоидного лейкоза (обзор литературы) // Клинич. лаб. диагностика. – 2003. – № 4. – С. 24, 33-40.
5. Земсков А.М., Караулов А.В., Земсков В.М. Комбинированная иммунокоррекция. – М.: Наука, 1994. – 260 с.
6. Савченко А.А., Сунцова Л.Н. Высокочувствительное определение активности дегидрогеназ в лимфоцитах периферической крови биолюминесцентным методом // Лаб. дело. – 1989. – № 11. – С. 23-25.
7. Савченко А.А., Шакина Н.А., Куртасова Л.М. Особенности иммунологических показателей крови и метаболических параметров лимфоцитов у больных гепатитами А и В // Журн. инфекционной патологии. – 1997. – Т. 4, № 4. – С. 24-27. Rai K.R., Dohner H., Keating M.J., Montserrat E. Chronic lymphocytic leukemia: case-based session / Process Citation. Hematology. – 2001. – P. 140-156.
8. Fayad L., Keating M.J., Reuben J.M. Kurzrock interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome // Blood. – 2001. – Vol. 97, N 1. – P. 256-263.
9. Kantarjian H.M., Brien S.O., Cortes J. Treatment of accelerated phase of philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML AP) with imatinib mesilate (STI 571) // Hematology. – 2001. – Orlando, Florida. – Abst. 594.
10. Kumas Sotiris, Semenova E.A., Turkina A.G., Zakharova A.V., Domracheva E.V., Khoroshko N.D., Frank G.A. Myelofibrosis in patients with chronic myeloid leukemia treated with interferon-alpha // Arkh. Patol. – 2003. – Vol. 65, N 4. – P. 9-12.
11. Nakamura M., Arai T., Magori E. Decrease in malate dehydrogenase activities in peripheral leucocytes of type 1 diabetic dogs // Res. Vet. Sci. – 2003. – Vol. 74, N 2. – P. 183-185.
Review
For citations:
Smirnova O.V., Manchuk V.T., Savchenko A.A. METABOLIC STATE OF BLOOD LYMPHOCYTES IN CHRONIC MYELOID LEUKEMIA AND CHRONIC LYMPHOID LEUKEMIA. Medical Immunology (Russia). 2008;10(1):21-26. (In Russ.) https://doi.org/10.15789/1563-0625-2008-1-21-26
Views:
1117
Email this article 